February 4, 2010 Growth in the quarter was driven by an increase in Specialty Injectable Pharmaceuticals, with sales in the Americas up 27% to $439.2 million, in Europe, Middle East & Africa, sales were $76.7 million (+21%), and in the Asia Pacific region, sales were
Michael Martorelli || November 6, 2009 Feel Better Now?
Ending one year, approaching the next
By Michael A. Martorelli
It’s always interesting to write a column about an event that is still in my future, but will have already happened by the time you read my words. Th…